Glooko acquires xbird, a company developing AI-driven just in time adaptive interventions.

Digital health company Glooko acquired xbird, a medical AI company with Just In Time Adaptive Intervention technologies to predict patient behavior and offer behavioral changes accordingly to improve outcomes for patients with diabetes.

Glooko, Inc., ein führender Anbieter von Datenmanagement- und Telemonitoringlösungen für Diabetes und andere chronische Erkrankungen, gab heute die Akquisition des Berliner Digital Health Unternehmens xbird bekannt.

Glooko has made a name for itself in digital health circles with its data management tools for diabetes patients and has now added artificial intelligence capabilities with its acquisition of xbird.

Transaktion erweitert Glookos Expertise um Machine Learning und Just-In-Time Adaptive Intervention (JITAI) Technologien

Digital diabetes and chronic condition management company Glooko announced it had acquired Berlin-based xbird, maker of AI-based diabetes care tools.

Der schwedische Anbieter von Datenmanagement- und Telemonitoringlösungen Glooko hat das Berliner Digital Health Unternehmens Xbird übernommen.

Adding Xbird’s machine learning software will help the Glooko platform better predict patients’ behavior and improve how they manage their diabetes by offering customized recommendations.

Glooko, Anbieter von Datenmanagement- und Telemonitoringlösungen für Diabetes und andere chronische Erkrankungen, übernimmt das Berliner Digital-Health-Unternehmen xbird.

Glooko is dipping into the field of artificial intelligence and machine learning with its acquisition of xbird.